MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-22-2023
NantHealth Total Liabilities 2011-2026 | NH
Annual Total Liabilities NantHealth
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 385 M | 360 M | 312 M | 324 M | 284 M | 256 M | 273 M | 227 M | 246 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 385 M | 227 M | 296 M |
Quarterly Total Liabilities NantHealth
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 397 M | 406 M | 385 M | 362 M | - | 358 M | 360 M | 364 M | 361 M | 320 M | 312 M | 312 M | 312 M | 312 M | 324 M | 324 M | 324 M | 324 M | 284 M | 284 M | 284 M | 284 M | 256 M | 256 M | 256 M | 256 M | 273 M | 273 M | 273 M | 273 M | 60.9 M | 60.9 M | 60.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 406 M | 60.9 M | 290 M |
Total Liabilities of other stocks in the Health information services industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
American Well Corporation
AMWL
|
76 M | $ 5.46 | - | $ 87.6 M |  USA |
 |
Accolade
ACCD
|
84.7 M | - | 0.29 % | $ 206 M | USA |
 |
Cerner Corporation
CERN
|
3.75 B | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
248 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
1.88 B | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
42.9 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
381 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.26 B | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
8.86 M | - | - | $ 102 M | USA |
 |
1Life Healthcare
ONEM
|
898 M | - | - | $ 3.37 B | USA |
 |
Akerna Corp.
KERN
|
14.6 M | - | - | $ 161 M | USA |
 |
HealthStream
HSTM
|
151 M | $ 22.05 | - | $ 670 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
1.02 B | - | -10.39 % | $ 886 M | USA |
 |
Evolent Health
EVH
|
958 M | $ 3.55 | -0.14 % | $ 333 M | USA |
 |
So-Young International
SY
|
776 M | $ 2.88 | - | $ 229 M |  China |
 |
HealthEquity
HQY
|
1.13 B | $ 81.15 | - | $ 6.94 B | USA |
 |
Teladoc Health
TDOC
|
1.47 B | $ 5.13 | - | $ 904 M | USA |
 |
MTBC
MTBC
|
21.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
Change Healthcare
CHNG
|
6.66 B | - | - | $ 9.03 B | USA |
 |
10x Genomics
TXG
|
224 M | $ 22.37 | - | $ 2.62 B | USA |
 |
SCWorx Corp.
WORX
|
1.86 M | $ 0.13 | - | $ 190 K | USA |
 |
Omnicell
OMCL
|
878 M | $ 41.53 | - | $ 1.91 B | USA |
 |
GoodRx Holdings
GDRX
|
663 M | $ 2.18 | - | $ 841 M | USA |
 |
Health Catalyst
HCAT
|
494 M | $ 1.95 | - | $ 117 M | USA |
 |
Progyny
PGNY
|
185 M | $ 17.79 | - | $ 1.53 B | USA |
 |
Premier
PINC
|
1.57 B | - | - | $ 2.33 B | USA |
 |
R1 RCM
RCM
|
1.1 B | - | - | $ 3.81 B | USA |
 |
Veeva Systems
VEEV
|
1.27 B | $ 188.48 | - | $ 30.3 B | USA |
 |
OptimizeRx Corporation
OPRX
|
56.8 M | $ 7.87 | - | $ 135 M | USA |
 |
NextGen Healthcare
NXGN
|
213 M | - | - | $ 1.6 B | USA |
 |
Phreesia
PHR
|
119 M | $ 12.63 | - | $ 689 M | USA |
 |
Schrödinger
SDGR
|
362 M | $ 13.12 | - | $ 964 M | USA |
 |
Zhongchao
ZCMD
|
1.73 M | $ 1.67 | - | $ 8.69 M | China |
 |
Signify Health
SGFY
|
924 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
23.3 M | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
441 M | - | - | $ 255 M | USA |